Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88-04), a synthetic alpha-picoline derivative, administered intravenously.

por Jodrell, D. I., Bowman, A., Stewart, M., Dunlop, N., French, R., MacLellan, A., Cummings, J., Smyth, J. F.
Publicado 1998

The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells

por Huang, J, Chen, K, Chen, J, Gong, W, Dunlop, N M, Howard, O M Z, Gao, Y, Bian, X-w, Wang, J M
Publicado 2010